Can low thyroid hormone physiology raise homocysteine?

Low thyroid hormone physiology—most clearly untreated overt hypothyroidism—can increase circulating homocysteine. The effect appears to reflect both impaired metabolic disposal and reduced renal handling, rather than a single isolated pathway.

Clinical evidence

• A systematic review/meta-analysis found higher homocysteine more consistently in overt hypothyroidism than in euthyroid individuals; findings in subclinical hypothyroidism were less consistent.
• Treatment-response data support a directional relationship: in one levothyroxine-treated cohort, median homocysteine fell 5.5 µmol/L (44%), and 7 of 8 participants with initially elevated values normalized after euthyroidism was restored.
• In contrast, a prospective cohort of 37 people with subclinical hypothyroidism had normal baseline homocysteine and no change after 3–4 months of levothyroxine. Thus, clinically significant hormone deficiency is the more reliable setting for this effect.

Mechanistic explanation

• Hypothyroid animal models show reduced activity of remethylation enzymes—MTHFR, methionine synthase, BHMT, SAM synthetase, and SAH hydrolase—and, in some models, reduced cystathionine β-synthase (CBS). These changes can constrain both remethylation of homocysteine to methionine and transsulfuration-based disposal.
• Renal physiology is likely especially important in humans. Hypothyroidism is associated with higher creatinine, lower estimated glomerular filtration rate (eGFR), and higher homocysteine; thyroid-hormone replacement can improve eGFR in parallel with lower homocysteine. Reduced filtration and renal metabolism therefore plausibly impair homocysteine elimination.

Clinical interpretation

• Folate status, and potentially vitamins B12 and B6, kidney function, diet, and tissue-specific enzyme responses can materially alter the observed level. Individual enzyme findings are less directly established in humans than the renal association.

Bottom line

• Low thyroid hormone physiology can raise homocysteine, particularly in overt untreated hypothyroidism, through impaired renal handling and likely disruption of remethylation/transsulfuration pathways. Thyroid replacement should be guided by established thyroid indications, not homocysteine alone.